TANDEM DIABETES CARE INC (TNDM) research
TANDEM DIABETES CARE INC- Sector
- Health Care
- Last price
- $15.22
- As of
TANDEM DIABETES CARE INC (TNDM): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-06.
As of . Source: SEC EDGAR filings for TNDM. Method and limitations.
Share the TNDM intelligence card
See TNDM live in the terminal
Track TNDM's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live TNDM terminal, freeActive signals for TNDM
- highCONSENSUS_BUY
3 tracked funds increased TNDM this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +579% to TNDM (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +233% to TNDM (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +72% to TNDM (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +4860% to TNDM (2026Q2)
FREE, NO ACCOUNT
Every signal on TNDM, as it fires
You are seeing 5 of 26 signals recorded on TNDM since 2026-05-26.
The five above landed across 2 days. The other 21 were recorded on 2 other days. 22 of the 26 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in TNDM (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 875372203 · 2026Q2 | $26.2M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 875372203 · 2026Q2 | $19.8M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 875372203 · 2026Q2 | $10.3M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 875372203 · 2026Q2 | $9.2M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 875372203 · 2026Q2 | $8.4M | 0.01% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TNDM
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
TNDM against its peers
TNDM's operating margin of -18.5% ranks in the 13th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-10-03 and 2026-01-02.
| Metric | TNDM | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.0B USD | 781M USD | 63 | 25 |
| Gross margin | 53.8% | 63.7% | 41 | 15 |
| Operating margin | -18.5% | 1.5% | 13 | 25 |
| Net margin | -20.2% | -0.4% | 13 | 25 |
| Return on equity | -131.9% | -0.2% | 6 | 25 |
| P / E | n/a | 44.1x | n/a | 10 |
Peers (25): USPH, GDRX, CERT, TDOC, OMDA, AMN, IRMD, PRCT, CSTL, CNMD, PNTG, STAA, OMCL, ATEC, BVS, TALK, HSTM, LMAT, VREX, NVCR, AHCO, XRAY, SEM, PGNY, EHAB. Fiscal periods ending between 2025-10-03 and 2026-01-02. Every figure is one full fiscal year read from one annual filing (TNDM: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more TNDM signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to TNDMand get the insider, 13F, options, and confluence read in one view.